Correction: Aging Clinical and Experimental Research (2022) 34:2625–2634 https://doi.org/10.1007/s40520-022-02272-z
In the published article, the author would like to update the following lines from
Gastrointestinal adverse events were observed in 31% (n = 319) participants and, of these, 85% (n = 271) were upper gastrointestinal.
History of Gastrointestinal symptoms were observed in 31% (n = 319) participants and, of these, 85% (n = 271) were upper gastrointestinal
in the published article.
The original article has been updated.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Fuggle, N., Al-Daghri, N., Bock, O. et al. Correction: Novel formulations of oral bisphosphonates in the treatment of osteoporosis. Aging Clin Exp Res 35, 1375–1376 (2023). https://doi.org/10.1007/s40520-022-02319-1